Cite Filings / CALC / 0001829126-25-007253
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

CalciMedica, Inc. · Filed 2025-09-09 · Acc 0001829126-25-007253

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-11-07 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-09-15 4 CHIEF BUSINESS OFFICER bought 5,000 shares at $3.12 ($15,600)
  • 2025-09-11 4 CHIEF BUSINESS OFFICER bought 2,343 shares at $3.15 ($7,378)
  • 2025-09-09 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-09-02 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-09-02 4 CHIEF BUSINESS OFFICER bought 10,000 shares at an average $2.85 ($28,532)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · CVI Investments, Inc. 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Stonepine Capital Management, LLC 8.1%
  3. 2026-11-16 SCHEDULE 13G/A · Armistice Capital, LLC 5.69%
  4. 2026-11-16 SCHEDULE 13G · StemPoint Capital LP 9.9%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…